Literature DB >> 8976663

Urinary growth hormone estimation in diagnosing severe growth hormone deficiency.

P Pirazzoli1, M Mandini, S Zucchini, S Gualandi, L Vignutelli, M Capelli, E Cacciari.   

Abstract

Urinary growth hormone was measured in 54 children with short stature who had growth hormone deficiency that was initially diagnosed pharmacologically (arginine and L-dopa) and physiologically (mean growth hormone concentration during sleep evaluated twice). Based on the growth hormone response to pharmacological tests the subjects were subdivided into three groups: group A, 20 subjects with normal response (peak concentration > 8 micrograms/l); group B, 20 subjects with response between 4 and 8 micrograms/l; and group C, 14 subjects with response < 4 micrograms/l. In group A four subjects had an abnormally low nocturnal mean growth hormone concentration (< or = 3.3 micrograms/l). In group C seven subjects had multiple pituitary hormone deficiency and abnormal magnetic resonance imaging. All subjects had urine collected from 8.00 pm to 8.00 am for 4-5 consecutive nights. A positive correlation was found between serum nocturnal mean growth hormone values and urinary growth hormone in all subjects. Mean (SD) concentrations of urinary growth hormone were similar in groups A (18.0 (9.5) ng/g creatinine) and B (13.6 (5.9) ng/g creatinine), but significantly higher than that of group C (3.4 (3.7) ng/g creatinine). Considering as abnormal urinary growth hormones below the lower limit of the range in group A, specificity and sensitivity of urinary growth hormone was 100% and 35% respectively. Sensitivity for groups B and C were 5% and 78% respectively. When considering only the subjects of group C with pathological magnetic resonance findings, sensitivity increased to 100%. In the four subjects of group A with mean growth hormone concentration < or = 3.3 micrograms/l, specificity decreased to 80%. It is concluded that urinary growth hormone assay is characterised by a sensitivity too low to be regarded as improving the traditional diagnostic approach to define growth hormone deficiency, unless it is used to identify subjects with the most severe deficiencies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976663      PMCID: PMC1511705          DOI: 10.1136/adc.75.3.228

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

1.  Human growth hormone (hGH) in urine and its correlation to serum hGH examined by a highly sensitive sandwich enzyme immunoassay.

Authors:  S Hashida; E Ishikawa; Y Kato; H Imura; Z Mohri; Y Murakami
Journal:  Clin Chim Acta       Date:  1987-01-30       Impact factor: 3.786

2.  Quantitation of urinary somatomedin-C and growth hormone in preterm and fullterm infants and normal children.

Authors:  T Quattrin; C H Albini; J F Cara; R L Vandlen; B J Mills; M H MacGillivray
Journal:  J Clin Endocrinol Metab       Date:  1988-04       Impact factor: 5.958

3.  Urinary growth hormone excretion rates in normal and acromegalic man: a critical appraisal of its potential clinical utility.

Authors:  L M Winer; M A Shaw; G Baumann
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

4.  Growth hormone secretory profiles: variation on consecutive nights.

Authors:  D L Donaldson; J G Hollowell; F P Pan; R A Gifford; W V Moore
Journal:  J Pediatr       Date:  1989-07       Impact factor: 4.406

5.  Urinary excretion of human growth hormone: daily variation and relationship with albumin and alpha 1-microglobulin in urine.

Authors:  N Hattori; A Shimatsu; Y Kato; H Koshiyama; Y Ishikawa; T Tanoh; H Assadian; H Imura
Journal:  Acta Endocrinol (Copenh)       Date:  1989-10

6.  Quantification of urinary growth hormone (GH) excretion by centrifugal ultrafiltration and radioimmunoassay: appraisal of the relationship between 24 h urinary GH and mean 24 h serum GH levels in normal and abnormal states of GH secretion.

Authors:  A J Weissberger; K Y Ho; M C Stuart
Journal:  Clin Endocrinol (Oxf)       Date:  1989-06       Impact factor: 3.478

7.  Comparison of physiologic and pharmacologic assessment of growth hormone secretion.

Authors:  S F Siegel; D J Becker; P A Lee; J P Gutai; T P Foley; A L Drash
Journal:  Am J Dis Child       Date:  1984-06

8.  Growth hormone neurosecretory dysfunction. A treatable cause of short stature.

Authors:  B E Spiliotis; G P August; W Hung; W Sonis; W Mendelson; B B Bercu
Journal:  JAMA       Date:  1984-05-04       Impact factor: 56.272

Review 9.  Is growth hormone deficiency a useful diagnosis?

Authors:  C G Brook; P C Hindmarsh; P J Smith
Journal:  Acta Paediatr Scand Suppl       Date:  1987

10.  Growth hormone in urine: development of an ultrasensitive assay applicable to plasma and urine.

Authors:  J Girard; T Erb; A Pampalone; A N Eberle; J B Baumann
Journal:  Horm Res       Date:  1987
View more
  2 in total

Review 1.  Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH.

Authors:  Claudia Fredolini; Davide Tamburro; Guido Gambara; Benjamin S Lepene; Virginia Espina; Emanuel F Petricoin; Lance A Liotta; Alessandra Luchini
Journal:  Drug Test Anal       Date:  2009-09       Impact factor: 3.345

2.  Plasma and urinary GH following a standardized exercise protocol to assess GH production in short children.

Authors:  A Sartorio; E Palmieri; V Vangeli; G Conte; M Narici; G Faglia
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.